These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26791603)

  • 1. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of endogenous A
    Goulding J; May LT; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A
    Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
    Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the G protein-coupling selectivity of the native A
    Gao ZG; Inoue A; Jacobson KA
    Biochem Pharmacol; 2018 May; 151():201-213. PubMed ID: 29225130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A
    Jiang J; Seel CJ; Temirak A; Namasivayam V; Arridu A; Schabikowski J; Baqi Y; Hinz S; Hockemeyer J; Müller CE
    J Med Chem; 2019 Apr; 62(8):4032-4055. PubMed ID: 30835463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.
    Hajiahmadi S; Panjehpour M; Aghaei M; Shabani M
    Biochem Cell Biol; 2015 Aug; 93(4):321-9. PubMed ID: 25877700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.
    Li Q; Ye K; Blad CC; den Dulk H; Brouwer J; Ijzerman AP; Beukers MW
    J Pharmacol Exp Ther; 2007 Feb; 320(2):637-45. PubMed ID: 17077318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent-Labeled Selective Adenosine A
    Köse M; Gollos S; Karcz T; Fiene A; Heisig F; Behrenswerth A; Kieć-Kononowicz K; Namasivayam V; Müller CE
    J Med Chem; 2018 May; 61(10):4301-4316. PubMed ID: 29681156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptors and diabetes: Focus on the A(2B) adenosine receptor subtype.
    Merighi S; Borea PA; Gessi S
    Pharmacol Res; 2015 Sep; 99():229-36. PubMed ID: 26142494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
    Bruzzese L; Fromonot J; By Y; Durand-Gorde JM; Condo J; Kipson N; Guieu R; Fenouillet E; Ruf J
    Cell Signal; 2014 May; 26(5):1060-7. PubMed ID: 24486403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.
    Eckle T; Grenz A; Laucher S; Eltzschig HK
    J Clin Invest; 2008 Oct; 118(10):3301-15. PubMed ID: 18787641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A
    Gao ZG; Jacobson KA
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S; Lacher SK; Seibt BF; Müller CE
    J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases.
    Eisenstein A; Patterson S; Ravid K
    J Cell Physiol; 2015 Dec; 230(12):2891-7. PubMed ID: 25975415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2B receptor modulates intestinal barrier function under hypoxic and ischemia/reperfusion conditions.
    Yang Y; Qiu Y; Wang W; Xiao W; Liang H; Zhang C; Yang H; Teitelbaum DH; Sun LH; Yang H
    Int J Clin Exp Pathol; 2014; 7(5):2006-18. PubMed ID: 24966910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.